
Opinion|Videos|October 9, 2024 (Updated: October 9, 2024)
Transforming MDD: A Patient's Journey with Rapid-Acting Therapy
A patient suffering from MDD, shares his story and the rapid benefits of patient experience with NMDA-targeted therapy, commenting on the tremendous quality of life benefit.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Postmodern Worldview and Contemporary Psychiatry
2
New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial: The Power of Another COMP360 Dose
3
DT120 (Lysergide) ODT Receives Breakthrough Therapy Designation for Treatment of MDD
4
New Phase 3 Data on Oveporexton for Narcolepsy Type 1
5








